Erythromycine Panpharma 500 mg
Erythromycine Panpharma 500 mg is a medicine authorised by Swissmedic under authorisation number 70183. The authorisation holder is Leman SKL SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 26 March 2026 and the authorisation is limited until 25 March 2031. ATC code J01FA01 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 70183 |
|---|---|
| Name | Erythromycine Panpharma 500 mg |
| Full name | Erythromycine Panpharma 500 mg, poudre pour solution à diluer pour perfusion |
| Authorisation holder | Leman SKL SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J01FA01 |
| First authorisation | 26 March 2026 |
| Authorisation validity | 25 March 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Erythromycine Panpharma 500 mg, poudre pour solution à diluer pour perfusion | A | 26 March 2026 |
| 2 | Erythromycine Panpharma 1 g, poudre pour solution à diluer pour perfusion | A | 26 March 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Ampulle(n) | J01FA01 | 08.01.6. | A |
| 2 | 10 | Ampulle(n) | J01FA01 | 08.01.6. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Erythromycine Panpharma 500 mg authorised in Switzerland?
Yes. Erythromycine Panpharma 500 mg is authorised by Swissmedic under authorisation number 70183, data as of 01 September 2026. The authorisation is limited until 25 March 2031.
Which dispensing category does Erythromycine Panpharma 500 mg have?
Erythromycine Panpharma 500 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Erythromycine Panpharma 500 mg?
The authorisation holder is Leman SKL SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.